Singapore markets open in 8 hours 50 minutes

GILD Jan 2026 42.500 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
1.30000.0000 (0.00%)
As of 02:46PM EDT. Market open.
Full screen
Previous close1.3000
Open1.3000
Bid1.4000
Ask1.5100
Strike42.50
Expiry date2026-01-16
Day's range1.3000 - 1.3000
Contract rangeN/A
Volume1
Open interest12
  • Zacks

    Insights Into Gilead (GILD) Q1: Wall Street Projections for Key Metrics

    Besides Wall Street's top -and-bottom-line estimates for Gilead (GILD), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2024.

  • Zacks

    Gilead Sciences (GILD) Increases Despite Market Slip: Here's What You Need to Know

    Gilead Sciences (GILD) closed the most recent trading day at $66.76, moving +0.91% from the previous trading session.

  • Reuters

    US FDA mandates label updates on CAR-T cancer therapies

    The U.S. Food and Drug Administration said on Thursday cancer therapies that use CAR-T technology will require changes to the so-called "boxed warning" to highlight the serious risk of T-cell blood cancer in patients who use these therapies. The health regulor has required related updates to other sections of the label such as warnings and precautions, postmarketing experience, patient counseling information and medication guide. In January, the FDA asked a host of drugmakers including Gilead Sciences, Johnson & Johnson and Novartis to add a boxed warning to their CAR-T cancer therapies, as it received reports of patients developing a type of T-cell blood cancer after being treated with them.